Article

Biomarkers for treatment outcome in newly diagnosed epilepsy

2017-01-01

Abstract excerpt

Introduction and aims Epilepsy is a common neurological condition and around 25% of patients are resistant to treatment with currently available drugs (Brodie et al., 2012). Currently there is only a limited ability to predict treatment outcome and no genome based biomarkers for treatment efficacy. The main aim for this thesis was to investigate clinical and genome based biomarkers for treatment response in newly...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9a182931-ba63-5a52-aa85-d67418b52af5
DOI: 10.17638/03006594

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Biomarkers for treatment outcome in newly diagnosed epilepsyDOI 10.17638/03006594Read

A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy.Semantic proximity Read

Clinical Prediction Models for Treatment Outcomes in Newly-diagnosed EpilepsySemantic proximity Read

METHYLATION BIOMARKERS ASSOCIATED WITH DRUG-RESISTANT EPILEPSYSemantic proximity Read

Pharmacogenomics and epilepsy: the road ahead.Semantic proximity Read

Personalized translational epilepsy research - Novel approaches and future perspectives: Part I: Clinical and network analysis approaches.Semantic proximity Read

Pharmacogenomics in epilepsy.Semantic proximity Read

Personalized translational epilepsy research - Novel approaches and future perspectives: Part II: Experimental and translational approaches.Semantic proximity Read

Genomics in the presurgical epilepsy evaluationSemantic proximity Read

A translational multimodal machine-learning prototype predicting valproate response in epilepsy treatmentSemantic proximity Read

A roadmap for precision medicine in the epilepsies.Semantic proximity Read

The epilepsy phenome/genome project.Semantic proximity Read

Multi-SNP pharmacogenomic classifier is superior to single-SNP models for predicting drug outcome in complex diseases.Semantic proximity Read